Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirofumi Mukai

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Japanese Journal of Clinical Oncology|April 13, 2010
Targeted therapy in breast cancer: current status and future directionsHirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Clinical diagnosis of primary unknown cancer-the present situation and problems]Hirofumi Mukai
International Journal of Clinical Oncology|July 16, 2010
Treatment strategy for HER2-positive breast cancerHirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2012
[Clinical evaluation of anti-cancer or targeted drugs and the optimal timing for changing therapeutics-breast cancer]Hirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[Clinical Practice of Carcinoma of Unknown Primary]Yoriko Hasegawa, Hirofumi Mukai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Treatment guidelines for systemic adjuvant therapy of breast cancer]Toru Watanabe, Hirofumi Mukai
Japanese Journal of Clinical Oncology|November 7, 2012
Ki-67 index guided selection of preoperative chemotherapy for HER2-positive breast cancer: a randomized phase II trialTakeshi Yamaguchi, Hirofumi Mukai
Breast Cancer (Tokyo, Japan)|June 29, 2012
The current status and future perspectives of CSPOR-BCTomohiko Aihara, Hirofumi Mukai
Chinese Clinical Oncology|July 31, 2018
Advances in chemotherapy for HER2-negative metastatic breast cancerHirofumi Mukai, Mayuko Ito
Japanese Journal of Clinical Oncology|May 1, 2010
Elderly breast cancer therapy: a Japanese experienceYoichi Naito, Hirofumi Mukai, Shunji Nagai
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Japanese Journal of Clinical Oncology|April 13, 2010
Targeted therapy in breast cancer: current status and future directionsHirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Clinical diagnosis of primary unknown cancer-the present situation and problems]Hirofumi Mukai
International Journal of Clinical Oncology|July 16, 2010
Treatment strategy for HER2-positive breast cancerHirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2012
[Clinical evaluation of anti-cancer or targeted drugs and the optimal timing for changing therapeutics-breast cancer]Hirofumi Mukai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 21, 2018
[Clinical Practice of Carcinoma of Unknown Primary]Yoriko Hasegawa, Hirofumi Mukai
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Treatment guidelines for systemic adjuvant therapy of breast cancer]Toru Watanabe, Hirofumi Mukai
Japanese Journal of Clinical Oncology|November 7, 2012
Ki-67 index guided selection of preoperative chemotherapy for HER2-positive breast cancer: a randomized phase II trialTakeshi Yamaguchi, Hirofumi Mukai
Breast Cancer (Tokyo, Japan)|June 29, 2012
The current status and future perspectives of CSPOR-BCTomohiko Aihara, Hirofumi Mukai
Chinese Clinical Oncology|July 31, 2018
Advances in chemotherapy for HER2-negative metastatic breast cancerHirofumi Mukai, Mayuko Ito
Japanese Journal of Clinical Oncology|May 1, 2010
Elderly breast cancer therapy: a Japanese experienceYoichi Naito, Hirofumi Mukai, Shunji Nagai
Pageof 16